Related Experiment Video
Updated: Feb 17, 2026

11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
18.7K
How is pediatric surgical innovation regulated?
1Seton Hall University School of Law, USA.
Seminars in Pediatric Surgery
|February 15, 2026
Summary
Navigating the regulatory "grey zone" in pediatric surgical innovation is crucial. Establishing surgical innovation committees with diverse perspectives can protect children and guide responsible advancements.
Area of Science:
- Medical Ethics
- Pediatric Surgery
- Regulatory Science
Background:
- Surgical innovation offers patient benefits but carries risks, particularly for pediatric patients.
- Ethical guidelines and oversight are vital for safe pediatric surgical innovation.
- Definitional challenges create a regulatory
Purpose of the Study:
- To review the regulatory landscape of surgical innovation, focusing on pediatric challenges.
- To identify mechanisms for ethically permissible clinical adaptation versus innovation requiring further review.
- To propose practical governance solutions for responsible pediatric surgical innovation.
Main Methods:
- Review of legal and regulatory frameworks impacting surgical innovation.
- Analysis of challenges specific to pediatric surgical innovation.
- Examination of existing and proposed governance models.
Main Results:
- Current regulations present a "grey zone" in distinguishing clinical adaptation from innovation needing review.
- Courts, federal agencies, state legislatures, and private regulators influence surgical innovation oversight.
- Pediatric surgery faces unique regulatory hurdles.
Conclusions:
- Surgical innovation committees integrating diverse expertise (surgical, clinical, ethical, caregiver) offer a practical governance model.
- These committees can protect pediatric patients and guide clinicians.
- Responsible innovation requires clear ethical guidelines and robust oversight mechanisms.
Related Concept Videos
Psychosurgery
1.9K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
1.9K
Pharmacokinetics in Pediatric Patients: Drug Excretion
284
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
284
Drug Regulation
3.1K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.1K
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
17
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
17
Pharmacokinetics in Pediatric Patients: Drug Metabolism
256
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
256
Neural Regulation
43.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
43.5K

